1. Home /
  2. Biotechnology

Biotechnology

Coming Up Short? Here Are Some Stocks to Consider

Coming Up Short? Here Are Some Stocks to Consider

To effectively generate profits, a trader must pick several companies in a sector and short the whole bunch.

In Search of That 'Tenbagger'

In Search of That 'Tenbagger'

Here are 2 stocks worthy of small positions within a well-diversified biotech portfolio for aggressive investors.

As 'Precision Medicine' Starts to Take Off, Here's Who's Poised to Capitalize

As 'Precision Medicine' Starts to Take Off, Here's Who's Poised to Capitalize

Precision medicine is like a smart bomb that bases treatment on a patient's individual genetics. One company makes the hardware and software to help make it happen.

Watch These 4 Japanese Drugmakers With Big Coming Events

Watch These 4 Japanese Drugmakers With Big Coming Events

Investors should keep tabs on these "focus events" from this quartet of U.S.-listed Japanese drugmakers that can make or break their treatments.

2 Attractive Biotechs With Key Study Outcomes on the Horizon

2 Attractive Biotechs With Key Study Outcomes on the Horizon

Intra-Cellular Therapies and Acadia Pharmaceuticals are worth investors' attention.

Bayer Rises; U.S. Judge to Cut $80 Million Roundup Jury Verdict

Bayer Rises; U.S. Judge to Cut $80 Million Roundup Jury Verdict

U.S. District Judge Vince Chhabria said that he would have a final ruling by the end of next week.

Merck Gets Boost From Analyst Buy Rating

Merck Gets Boost From Analyst Buy Rating

Shares of pharmaceutical giant Merck gain after Mizuho Securities initiates coverage with a buy rating and a 12-month price target of $97 a share.

Buyout Speculation Picks Up in Biotech

Buyout Speculation Picks Up in Biotech

Here's my take on the M&A landscape as well as my own speculation of some possible logical buyout targets.

Sen. Elizabeth Warren Urges New Pfizer Board Member Gottlieb to Resign

Sen. Elizabeth Warren Urges New Pfizer Board Member Gottlieb to Resign

The Senator says that Gottlieb's appointment to the company's board smacks of the Washington revolving door that has become prevalent.

Pfizer Gains on Positive Children-Dermatitis Treatment Results

Pfizer Gains on Positive Children-Dermatitis Treatment Results

Shares of Pfizer rise after the company announces positive results in a late-stage, non-steroid trial of a treatment for chronic dermatitis, or eczema, in kids.